A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Synopsis Routine use of continuous positive airway pressure (CPAP) to support preterm infants with respiratory distress is an evidenced based strategy to decrease the incidence of bronchopulmonary dysplasia (BPD). However, rates of CPAP failure remain unacceptably high (50-60%) in very premature neonates (< 26 weeks' gestation), who are at high risk for developing BPD. Here, using the GRADE framework to assess the quality of available evidence, we review strategies aimed at decreasing CPAPdoi:10.1016/j.clp.2018.01.011 pmid:29747887 pmcid:PMC5953203 fatcat:3mtaihctavaz5gwoebyo2riwkq